Drugs / Iron III Hydroxide Polymaltose Complex
Iron III Hydroxide Polymaltose Complex
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07391371 | Feb → Oct 2026 expected | iron deficiency anemia | University of Medicine, Mandalay | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT00479102 | May 2007 → ? | anemia, disorder of iron metabolism and transport | Soroka University Medical Center | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01857011 Comparator | Apr 2014 → Apr 2016 | iron deficiency anemia | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06631612 Comparator | Jan 2024 → Jan 2025 overdue | iron deficiency anemia | Ain Shams University | Active not recruiting | No outcome recorded |
| Phase 4 | NCT02487719 Comparator | Jun 2015 → Jun 2016 | iron deficiency anemia, pregnancy disorder | University of Zurich | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06624709 Comparator | Nov 2024 → Sep 2026 expected | — | Riccardo Pfister | Recruiting | No outcome recorded |
| — | NCT06437080 Comparator | Oct 2022 → Oct 2025 | disorder of iron metabolism and transport, iron metabolism disease | Akram Medical Complex | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron (III)-hydroxide polymaltose complex | “Oral iron(III)-hydroxide polymaltose complex 100 mg twice daily in the fist 8 postoperative weeks.” NCT01857011 ↗ |
| Known as | ferric hydroxide polymaltose complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06631612 ↗ |
| Known as | Ferripel-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479102 ↗ |
| Known as | Iron polymaltose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02487719 ↗ |
| Known as | maltofer | “This arm will receive 2-3mg/kg/d of maltofer 4 times a day” NCT06624709 ↗ |
| Route | Oral | “iron polymaltose complex administered orally” PMID 27068478 ↗ Apr 2016 |